What is Zacks Small Cap’s Forecast for MGRM Q1 Earnings?

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics in a report released on Thursday, March 13th. Zacks Small Cap analyst T. Kerr anticipates that the company will post earnings per share of ($0.10) for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Zacks Small Cap also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.44) EPS and FY2026 earnings at ($0.16) EPS.

Monogram Orthopaedics (NASDAQ:MGRM) last issued its earnings results on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Several other research firms have also recently weighed in on MGRM. Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They issued a “buy” rating and a $4.00 price target on the stock. Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Monogram Orthopaedics Stock Up 0.9 %

NASDAQ:MGRM opened at $2.33 on Monday. The business’s 50-day moving average price is $2.54 and its two-hundred day moving average price is $2.49. Monogram Orthopaedics has a twelve month low of $1.53 and a twelve month high of $4.90. The stock has a market cap of $79.95 million, a P/E ratio of -4.96 and a beta of 1.66.

Hedge Funds Weigh In On Monogram Orthopaedics

A number of large investors have recently modified their holdings of the company. Geode Capital Management LLC raised its holdings in shares of Monogram Orthopaedics by 7.7% during the 4th quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock valued at $537,000 after buying an additional 16,234 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Monogram Orthopaedics by 110.6% during the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock valued at $109,000 after buying an additional 24,088 shares in the last quarter. Commonwealth Equity Services LLC raised its holdings in shares of Monogram Orthopaedics by 21.5% during the 4th quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock valued at $99,000 after buying an additional 7,366 shares in the last quarter. Fiduciary Family Office LLC purchased a new position in shares of Monogram Orthopaedics during the 4th quarter valued at about $70,000. Finally, State Street Corp purchased a new position in shares of Monogram Orthopaedics during the 3rd quarter valued at about $62,000. 0.45% of the stock is owned by hedge funds and other institutional investors.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.